You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The first edition of Asbestos: Risk Assessment, Epidemiology, and Health Effects received critical acclaim due to the interdisciplinary nature of its content. Editors Ronald Dodson and Samuel Hammar have carefully kept this popular focus while updating and expanding the topics covered in the first edition with the help of internationally known expe
Dail and Hammar’s Pulmonary Pathology has established itself as the definitive reference in the field. This third edition is now a two-volume, full color text and has been thoroughly updated to cover newly recognized entities and the latest advances in molecular diagnostic techniques. It is abundantly illustrated with more than 2,000 illustrations in total, 1,900 of which are in full color. This first volume focuses on Nonneoplastic lung diseases, and Volume II covers Neoplastic Lung Diseases. It is an outstanding contribution to pathology literature and a must-have for the library of every surgical and pulmonary pathologist.
The first edition of Pulmonary Pathology was dedicated to Vascular Diseases. Vasculitis is so complex as to con two giants in the field, Drs. Averill Liebow and Herbert tinue to warrant a separate chapter. Spencer. The current edition is dedicated to all those Each chapter has been updated and revised. Exten who have contributed and are contributing to the field, sive expansion has occurred in Bacterial Infections, Rheumatic Connective Tissue Diseases, Asbestos, those whose individual contributions and queries create its rich fabric. It is our pleasure and honor to summarize Vasculitis, Common Neoplasms, Uncommon Lung the work of many of these individuals. Tumors and Pleural Diseases. Despit...
While there are hundreds of books available on many different aspects of asbestos, none contain the encyclopedic, comprehensive coverage you will find here. Edited by leading authorities, with contributions from specialists and leaders in their respective fields, Asbestos: Risk Assessment, Epidemiology, and Health Effects provides a cross-disciplinary approach and an authoritative review of asbestos research. The breadth and depth of coverage spans history, pathology, epidemiology, as well as sampling, analysis, and regulatory issues. Following the path of asbestos from its natural sources to its effects at the cell, organism, and population levels, the volume covers testing methods, types o...
The first edition of Asbestos: Risk Assessment, Epidemiology, and Health Effects received critical acclaim due to the interdisciplinary nature of its content. Editors Ronald Dodson and Samuel Hammar have carefully kept this popular focus while updating and expanding the topics covered in the first edition with the help of internationally known experts. While there are hundreds of books available on many different aspects of asbestos, none contain the encyclopedic, comprehensive coverage you will find here. See What’s New in the Second Edition: Definitions of asbestos by different methodologies and the potential impact that those forms have on health Internationally accepted sampling/analyt...
Documents the enormous contribution electron microscopy has made to the study of lung biology, describing new analytical instruments, recent technological developments, and future avenues of research. Illustrated with 290 micrographs of normal and abnormal lung, rare tumors, and other features of lu
Asbestos: Risk Assessment, Epidemiology, and Health Effects offers a key text on the evolving information regarding asbestos and human health. Now in its third edition, this bestseller explores the pathological complexities of asbestos-related disease and examines how asbestos induces diseases in biological systems. The book also discusses the types of instruments and methods available for evaluation of the content of asbestiform minerals in products, air, water, surface areas, and tissue. It explains the relevance of each of these applications and gives readers the tools to evaluate data in the future. Edited by leading authorities on the subject and with contributions from a team of intern...
Taken from the acclaimed Second Edition of Pulmonary Pathology, these five core chapters on benign and malignant pulmonary and pleural tumors now comprise an authoritative text in their own right. Over 850 illustrations - gross dissection specimens, photomicrographs, electron micrographs, radiographs, CT scans and more - of the same top quality found in the parent volume supplement the text. Of special note: problem areas in diagnosis are discussed from the viewpoints of three experienced pulmonary pathologists. More compact and convenient to use than its encyclopedic parent volume, Pulmonary Pathology - Tumors is ideal for pathologists, including residents, who need strategically focussed coverage of the tumors typically encountered in practice.
This volume examines our current understanding of the biological effects of fibrous and particulate substances, including discussions on nanoparticles. It offers comprehensive information on the latest insights into the immunological effects of various irritants on the human body. Readers will benefit from the contributing authors’ diverse perspectives and extensive discussions of key issues, which include molecular alterations of the immune system and autoimmune diseases in connection with asbestos and silica, among others. The chapters also discuss recommendations, practical methods, and nanosafety science in situations involving exposure to nanotoxic substances. Edited in collaboration with the Japanese Society for Hygiene, this book provides up-to-date information on the immunological effects of nanotoxic substances to researchers interested in environmental and occupational health. Presenting a number of recent concepts and findings in the field, it enables readers to gain a comprehensive knowledge of health problems caused by environmental fibrous and particulate substances.
Assesses ways to determine how well medical treatments actually work. Presents a new strategy for medical effectiveness research called "cross design synthesis" which represents an important step in advancing knowledge about the effectiveness of medical treatments, based not only on the results of randomized clinical trials but also on data reflecting wide experience in the field. Charts and tables.